“…Overall, the scant reports of SARS-CoV-1-associated neurological sequelae contrast strikingly with the high proportion of COVID-19 patients who go on to experience NC-PASC [14]. Headache, inattention [2,10], cognitive impairment [15], memory impairment, peripheral nerve disorders (including Guillain-Barré syndrome), movement disorders, stroke [16], numbness/tingling, dysgeusia, anosmia, dizziness, blurry vision, and tinnitus [17] SARS-CoV-1 Coronaviridae Respiratory tract epithelial cells [95] Cognitive impairment, sleep disturbance [96], neuromusculoskeletal disorders [97], peripheral neuropathy [98], Guillain-Barré syndrome, and stroke [94] HSV-1, HSV-2, VZV Herpesvirinae Epithelial cells, sensory ganglia during latency [101] Herpes labialis (cold sores), herpes zoster (shingles), and encephalitis [102] EBV Herpesvirinae B cells, nasopharyngeal epithelial cells, and CNS neuronal cells [103] Combative behavior, seizures, headache [104], "Alice in Wonderland" syndrome, facial nerve palsy, progressive microcephaly, and encephalitic illness [105,106] CMV Herpesvirinae Epithelial cells, endothelial cells, fibroblasts, smooth muscle cells [107],…”